Christopher Lucchessi

9PUBLICATIONS
16CO-AUTHORS
Predictive and prognostic markersMolecular targetsMechanobiologyHaematological tumoursRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 13, 2026
Molecular Characterization of PARP Inhibitor Response Reveals Co-Targeting Strategies in Advanced Prostate Cancer.

|Mar 07, 2025
ANGEL2 Modulates Wild-type TP53 Translation and Doxorubicin Chemosensitivity in Colon Cancer.

Christopher August Lucchesi, Saisamkalpa Mantrala, Darren Tran

|Aug 29, 2024
Alterations in Tumor Aggression Following Androgen Receptor Signaling Restoration in Canine Prostate Cancer Cell Lines.

Demitria M Vasilatis, Neelu Batra, Christopher A Lucchesi

|Jan 11, 2024
Ninjurin 2, a Cell Adhesion Molecule and a Target of p53, Modulates Wild-Type p53 in Growth Suppression and Mutant p53 in Growth Promotion.

Jin Zhang, Xiangmudong Kong, Hee Jung Yang

|Jul 29, 2023
Pesticides and Bladder Cancer: Mechanisms Leading to Anti-Cancer Drug Chemoresistance and New Chemosensitization Strategies.

Christopher A Lucchesi, Demitria M Vasilatis, Saisamkalpa Mantrala

|May 16, 2023
Molecular Similarities and Differences between Canine Prostate Cancer and Human Prostate Cancer Variants.

Demitria M Vasilatis, Christopher A Lucchesi, Paramita M Ghosh

Pageof 2

Frequent Collaborators

5 joint publications

Xinbin Chen

4 joint publications

Jin Zhang

4 joint publications

Paramita M Ghosh

3 joint publications

Demitria M Vasilatis